Skip to content

Clinical observation of piracetam injection in the treatment of cerebral infarction patients

Clinical observation of piracetam injection in the treatment of cerebral infarction patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034474
Enrollment
Unknown
Registered
2020-07-06
Start date
2020-07-15
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral infarction

Interventions

single arm:piracetam injection

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of cerebral infarction; 2. Age from 18 to 80 years old (including boundary value), regardless of gender; 3. Evidence of cerebral vascular lesions (MRI/MRA/CT, etc.); 4. Admission score <= 4 <= NIHSS score <= 20; 5. The patient or the patient's family member or guardian signs the informed consent and agrees to participate in all visits as required by the study programme.

Exclusion criteria

Exclusion criteria: 1. Patients with prior cognitive dysfunction, mental disorder, delirium, moderate mental depression, complete disorder of consciousness or aphasia; 2. Those who are known to be allergic to piracetam or other pyrrolidone derivatives for injection, or have allergic constitution; 3. Lactation patients, pregnancy or planned pregnancy; 4. Participated in or is currently participating in clinical research of other drugs or medical devices within the first three months of the study; 5. Other conditions that the researcher considers inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
MMSE score;

Secondary

MeasureTime frame
NIHSS score;mRS score;The incidence of recurrent events;

Countries

China

Contacts

Public ContactHuifang Xie

Zhujiang Hospital of Southern Medical University

xhffhx@126.com+86 13719340538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026